Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Healthcare

The GLG Healthcare Practice provides access to a global network of more than 55,000 experts from across the entire healthcare industry including physicians, researchers, scientists, and healthcare industry executives.

The Healthcare Practice provides insight into issues affecting the pharmaceutical, biotechnology, medical device, and healthcare services sectors.

Leading Experts on Healthcare

David Ziolkowski, COO/CIO, DOCTOR'S MEDICAL CENTER-SAN PABLODavid Ziolkowski

COO/CIO
DOCTOR'S MEDICAL CENTER-SAN PABLO
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Ziolkowski is COO/CIO of Doctors Medical Center in San Pablo, CA. He is responsible for all hospital operations, as well as all Hospital IT functions. Prior to that, Mr. Ziolkowski was Senior Vice President and Chief Information Officer at the Sampson Regional Medical Center in Clinton, NC. He...

Hany Salama, Vice President, Commercial Operations, NEOSTRATA COMPANY, INC.Hany Salama

Vice President, Commercial Operations
NEOSTRATA COMPANY, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Hany Salama, ME, MBA, CPM, is the Vice President, Commercial Operations at The NeoStrata Company. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible for all new commercial productlaunches...

Keith Berman, MPH, MBA, Consultant, HEALTH RESEARCH ASSOCIATESKeith Berman, MPH, MBA

Consultant
HEALTH RESEARCH ASSOCIATES
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Keith Berman, MPH, MBA, founded Health Research Associates in 1996. HRA provides reimbursement consulting, business development and market research services to leading biopharmaceuticals, blood products and medical device manufacturers and suppliers. Previously, Mr. Berman worked for ten years in product...

Samir Mehta, MD

Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Samir Mehta, MD, is an orthopaedic surgeon at the Hospital of the University of Pennsylvania. Previously, he was an Instructor at Harborview Medical Center and Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of PennsylvaniaHealth...

Louis Rocco

System Director of Purchasing
HALLMARK HEALTH SYSTEM, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Louis Rocco is the System Director of Purchasing at Hallmark Health System, in Massachusetts. He has over 25 years of experience in purchasing and has negotiation, analytical, reporting and communication skills in inventory, distribution, purchasing, mailroom, reimbursement and accounts payable background....

View All Leading Experts in Healthcare

GLG Study Groups in Healthcare(?)

Study Group Name No. Members
Oncologists (US) 2257
Pharmacists (US) 2079
Obstetricians/Gynecologists 1962
Neurologists 1866
Pediatricians (US) 1717

View All Study Groups in Healthcare

GLG NewsSM Analyses in Healthcare(?)

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

Novartis, Sleeping Giant Wakes-Up in China

November 6, 2009

Novartis to invest US$ 1 bn to build largest pharma R&D institute in China | www.pharmabiz.com

Novartis to grow its China presence, late.Novartis has a slow response to market opportunities.GlaxoSmithKline and other big pharma players are perhaps too large to compete in the world's changing markets.

Is GE Global Research Developing a Portable Solar-Powered Ultrasound Device?

November 6, 2009

GE Global Research bags US$ 1.2 mn NIH project for developing technology in prenatal care | www.pharmabiz.com

As the recipient of a new NIH grant, GE Healthcare should create and design new innovative features as a way to differentiate its products in the nascent point-of-care portable ultrasound marketplace.  Reasons why GE Healthcare should pursue a risk-taking strategy, such as developing a portable solar-powered...

Potential impact of large clinical trial on Liquid based cytology market

November 5, 2009

Robert Boorstein, MD, PhD, Associate Professor, Pathology, NEW YORK UNIVERSITY (INC)

Alternative to Pap Test Does Not Appear to Be Better for Detecting Cervical Cancer | www.medcompare.com

The data confirms what has long been known. There has never been definitive evidence for a benefit for Liquid based cytology screening compared with conventional screening, especially when sample collection is standardized and the laboratory meets reasonable standards.Objectively, liquid based cytology...

FDA Publishes H1N1 Diagnostic Test Guidance

November 5, 2009

Ken Powell, President, Genesis Business Development, LLC

FDA Publishes Guidance Document for H1N1 Dx | www.genomeweb.com

The FDA published document designed to help diagnostic test manufactures develop H1N1 tests and data that would accompany a FDA application to market them.  This follows on the recent issuance of CDC guidelines for H1N1 tests.

Genomic Health Posts a 41% Q3 Revenue Increase

November 5, 2009

Ken Powell, President, Genesis Business Development, LLC

Genomic Health Posts 41 Percent Revenue Increase for Q3 | www.genomeweb.com

Genomic Health (NASDAQ: GHDX) posted Q3 revenues that were 41% greater than Q3 08.  Virtually all of the revenue out performance was due to sales of the company's Oncotype Dx molecular diagnostic test for breast cancer used in developing a therapeutic strategy and assessing risk of recurrence.

View All GLG News in Healthcare

Engage a member of GLG Healthcare councils

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
7 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software

GLG Clients have access to 55,000+ Healthcare Members Globally:

Healthcare Providers
33,000+
Healthcare Industry Experts
17,000+
Cardiologists
2,500+
Hospital Administrators
1,700+
Pharmacists
1,200+

Become a Council Member

GLG Research StudySM

245 U.S.-based neurologists share their opinion of Tysabri for the treatment of multiple sclerosis.

GLG Research Study: 245 Neurologists on Tysabri for MS

GLG Vital SignsSM

Reactions from ten top medical oncologists, powered by the GLG Healthcare CouncilsSM, regarding data presented by Amgen and Bayer at the 34th European Society of Medical Oncology (ESMO) Congress in Berlin the week of September 21, 2009.

GLG Vital Signs: Post-ESMO Impact: Nexavar/Denosumab